ArticleUrolithiasis2025
Cooling-induced brushite crystallization in urine as a predictive risk marker for calcium kidney stone recurrence.
Article in Urolithiasis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Kidney stones have a high recurrence rate-10% within 5 years and 50% within 10. Crystalluria reflects the urinary physicochemical environment and may serve as a recurrence marker, but key crystals like brushite are rarely detected under ambient conditions. This study aimed to identify novel recurrence markers by inducing crystallization through urine cooling and analyzing crystal composition. The analyzed urine samples from 164 stone formers, including first-time stone formers (FSF, n = 77) and recurrent stone formers (RSF, n = 87). The RSF group was further stratified into low-risk (n = 43) and high-risk (n = 44) groups based on recurrence intervals. A 24-hour urine test assessed mineral composition and supersaturation indices. Urine samples were then cooled to induce crystallization; precipitated crystals were analyzed using microscopy and Raman spectroscopy. The presence, size, and quantity of brushite crystals were compared among the groups. Before cooling, crystals were detected in only 10.9% of samples, whereas after cooling, crystallization occurred in 76.2%, revealing six crystal types, including calcium oxalate dihydrate (COD) and brushite. COD prevalence did not differ significantly among the groups, whereas brushite crystals were significantly more frequent in the high-risk RSF (47.7%) than in low-risk RSF (16.3%) and FSF (16.9%) (p = 0.002) groups. Additionally, the high-risk RSF group had greater quantity and larger size of brushite crystals than did other groups. Cooling-induced brushite crystallization is a promising risk marker for early stone recurrence, with higher crystal quantity and larger size strongly associated with high-risk patients. This method might enhance predictive accuracy beyond traditional 24-hour urine tests, providing a simple, cost-effective tool for recurrence prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.